Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$118.49

0.93 (0.79%)

06:43
10/18/16
10/18
06:43
10/18/16
06:43

Johnson & Johnson boosts FY16 adj. EPS view to $6.68-$6.73, consensus $6.69

Backs FY16 revenue guidance of $71.5B-$72.2B, consensus $72.08B.

  • 18

    Oct

  • 06

    Nov

JNJ Johnson & Johnson
$118.49

0.93 (0.79%)

08/24/16
JEFF
08/24/16
NO CHANGE
Target $210
JEFF
Buy
Cooper Companies estimates raised at Jefferies after doctor survey
Jefferies analyst Anthony Petrone reports that the firm's survey of 52 new optometry practices suggest continued gains in dailies and stable share in monthlies for Cooper Companies (COO) and that Johnson & Johnson's (JNJ) Acuvue Vita is off to slow start. Based on the survey results, and a "significant" foreign exchange tailwind, Petrone raised his estimates for Cooper and increased his price target on the shares to $210 from $190. The firm has a Buy rating on Cooper shares.
09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
09/19/16
LEER
09/19/16
NO CHANGE
LEER
Abbott, Johnson & Johnson transaction positive for both companies, says Leerink
Leerink analyst Danielle Antalffy says the sale of Abbott's (ABT) Medical Optics ophthalmology business to Johnson & Johnson (JNJ) is positive for both companies. The deal strengthens Abbott's balance sheet and eliminates the need for a previously expected $3B capital raise, and adds a key component to Johnson & Johnson's already-strong vision care franchise, the analyst notes.
10/07/16
RBCM
10/07/16
NO CHANGE
RBCM
Johnson & Johnson weakness creates buying opportunity, says RBC Capital
RBC Capital analyst Glenn Novarro says that Johnson & Johnson underperformed the market in Q3 due to a number of factors including Remicade biosimilar risk and the pharma pricing debate. The analyst says that "these concerns are manageable/overblown," and he expects the company to report strong Q3 results, driven by a strong pharma performance. Novoroo expects the company's Q3 revenue to come in slightly above expectations, and he predicts that the company will narrow its 2016 EPS guidance to the high end of the previous range. The analyst recommends buying the stock. He keeps a $133 price target and Outperform rating on the shares.

TODAY'S FREE FLY STORIES

13:55
04/28/17
04/28
13:55
04/28/17
13:55
General news
Action Economics Survey results: »

Action Economics Survey…

T

AT&T

$39.69

-0.22 (-0.55%)

13:52
04/28/17
04/28
13:52
04/28/17
13:52
Hot Stocks
AT&T invested nearly $7.2B in California wireless and wired networks »

AT&T invested nearly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

  • 16

    May

  • 17

    May

LL

Lumber Liquidators

$24.50

0.14 (0.57%)

13:51
04/28/17
04/28
13:51
04/28/17
13:51
Options
Bullish earnings play in Lumber Liquidators »

Bullish earnings play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

QCOM

Qualcomm

$53.21

0.17 (0.32%)

, AAPL

Apple

$143.79

0.11 (0.08%)

13:50
04/28/17
04/28
13:50
04/28/17
13:50
Recommendations
Qualcomm, Apple analyst commentary  »

Oppenheimer doesn't…

QCOM

Qualcomm

$53.21

0.17 (0.32%)

AAPL

Apple

$143.79

0.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 08

    May

SPY

SPDR S&P 500 ETF Trust

$238.16

-0.44 (-0.18%)

, IVV

iShares Core S&P 500

$239.68

-0.41 (-0.17%)

13:46
04/28/17
04/28
13:46
04/28/17
13:46
Technical Analysis
On The Fly: ETF fund flow highlights »

Per data from ETF.com,…

SPY

SPDR S&P 500 ETF Trust

$238.16

-0.44 (-0.18%)

IVV

iShares Core S&P 500

$239.68

-0.41 (-0.17%)

VOO

Vanguard S&P 500 ETF

$218.65

-0.37 (-0.17%)

IWM

iShares Trust Russell 2000 Index Fund

$139.61

-1.34 (-0.95%)

QQQ

PowerShares QQQ Trust

$135.75

0.81 (0.60%)

XLF

Financial Select Sector

$23.62

-0.145 (-0.61%)

IEMG

iShares Core MSCI Emerging Markets

$48.67

0.065 (0.13%)

EZU

iShares MSCI Eurozone ETF

$39.33

0.0493 (0.13%)

TLT

iShares 20+ Year Treasury Bond Fund

$122.08

-0.04 (-0.03%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$88.16

0.01 (0.01%)

XLP

Consumer Staples Sector SPDR

$55.11

-0.09 (-0.16%)

VNQ

Vanguard REIT Index Fund

$82.86

-0.8037 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPN

Calpine

$10.00

0.41 (4.28%)

13:31
04/28/17
04/28
13:31
04/28/17
13:31
Options
Calpine calls active after earnings »

Calpine calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:30
04/28/17
04/28
13:30
04/28/17
13:30
General news
NY Fed accepted $181.98 B in daily reverse repos »

NY Fed accepted $181.98 B…

ALDR

Alder Biopharmaceuticals

$21.35

-0.8 (-3.61%)

13:25
04/28/17
04/28
13:25
04/28/17
13:25
Hot Stocks
Alder Biopharmaceuticals presents 'positive' Phase 2b data for Eptinezumab »

Alder BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

OCN

Ocwen

$2.26

0.03 (1.35%)

13:22
04/28/17
04/28
13:22
04/28/17
13:22
Periodicals
CFPB was seeking Ocwen settlement in $50M range, IMF reports »

The Consumer Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 24

    May

BCEI

Bonanza Creek

$0.79

0.0099 (1.27%)

13:21
04/28/17
04/28
13:21
04/28/17
13:21
Hot Stocks
Breaking Hot Stocks news story on Bonanza Creek »

Bonanza Creek trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:17
04/28/17
04/28
13:17
04/28/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
04/28/17
04/28
13:16
04/28/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAN

Banco Santander

$6.53

0.08 (1.24%)

13:16
04/28/17
04/28
13:16
04/28/17
13:16
Options
Banco Santander put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
04/28/17
04/28
13:15
04/28/17
13:15
General news
Energy Action: Baker-Hughes »

Energy Action:…

BCEI

Bonanza Creek

$0.79

0.0099 (1.27%)

13:10
04/28/17
04/28
13:10
04/28/17
13:10
Hot Stocks
Bonanza Creek announces emergence from Chapter 11 bankruptcy »

Bonanza Creek Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:06
04/28/17
04/28
13:06
04/28/17
13:06
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 4/28 Baker-Hughes…

MSI

Motorola Solutions

$85.88

-0.19 (-0.22%)

13:04
04/28/17
04/28
13:04
04/28/17
13:04
Hot Stocks
Motorola Solutions: ITC to probe unfair trade practices by Hytera »

Motorola Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 31

    May

BCEI

Bonanza Creek

$0.79

0.0049 (0.63%)

13:03
04/28/17
04/28
13:03
04/28/17
13:03
Hot Stocks
Breaking Hot Stocks news story on Bonanza Creek »

Bonanza Creek trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHI

Baker Hughes

$59.34

-0.31 (-0.52%)

13:03
04/28/17
04/28
13:03
04/28/17
13:03
Hot Stocks
Baker Hughes reports U.S. rig count up 13 to 870 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBP

Huttig Building Products

$9.03

0.28 (3.20%)

13:01
04/28/17
04/28
13:01
04/28/17
13:01
Hot Stocks
Huttig Building announces national distribution pact with Knauf Insulation »

Huttig Building Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

13:00
04/28/17
04/28
13:00
04/28/17
13:00
General news
Breaking General news story  »

Federal Reserve Board of…

HNHPF

Hon Hai Precision

12:59
04/28/17
04/28
12:59
04/28/17
12:59
Periodicals
Foxconn to invest in U.S., Reuters reports »

Terry Gou, chairman of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEF

iShares 7-10 Year Treasury Bond ETF

$106.48

-0.015 (-0.01%)

12:51
04/28/17
04/28
12:51
04/28/17
12:51
Options
$7.7M vote of confidence in iShares 7 to 10 year Treasury Bond ETF »

$7.7M vote of confidence…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPN

Calpine

$9.95

0.3599 (3.75%)

12:48
04/28/17
04/28
12:48
04/28/17
12:48
Periodicals
Calpine viewed as potential leveraged buyout target, SparkSpread says »

Comments from Calpine CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
04/28/17
04/28
12:45
04/28/17
12:45
General news
Breaking General news story  »

Week of 4/28 Baker-Hughes…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.